As its name suggests, the **cord blood bank** provides conditions for **stem cells** found in cord blood to be collected under specific conditions and stored in a bank. This ensures that if stem cells are ever needed for transplantation, this valuable resource is readily available and can be used for the transplant. Alongside other current sources for obtaining stem cells, **cord blood**, which was once discarded as biological waste, has gained attention. The blood that circulates in the umbilical cord and placenta during a mother's pregnancy, and is discarded after birth, is a rich source of stem cells, particularly **hematopoietic stem cells**. These can be used in the treatment of malignant diseases such as **thalassemia**, various types of **blood cancers**, **immune system deficiency diseases**, and **congenital anemias** of blood origin.

Over the past years, with increasing public awareness in the field of cellular and stem cell sciences, and the expanding use of stem cells in treating various diseases on one hand, and the growth of Royan Stem Cell Technology Company's services on the other, the number of applicants for storing newborn umbilical cord blood throughout the country has significantly increased. Therefore, in order to enable all our dear compatriots to benefit from the umbilical cord blood stem cell storage service, this company has established **over 40 representative offices** in all provinces.

Royan Stem Cell Technology Company, possessing advanced technology and aiming to ensure the sustainable quality of its services, established a Quality Assurance Unit approximately 8 years ago. This unit began its activities based on the requirements of the international standards Fact-Netcord and AABB, as well as Iran's national umbilical cord blood standards (developed by the Ministry of Health, Treatment, and Medical Education), to ensure the compliance of organizational processes with international standards.